Form 8-K - Current report:
SEC Accession No. 0001641172-25-003232
Filing Date
2025-04-08
Accepted
2025-04-08 16:30:29
Documents
14
Period of Report
2025-04-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 67069
2 ex10-1.htm EX-10.1 134005
  Complete submission text file 0001641172-25-003232.txt   413179

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cocp-20250402.xsd EX-101.SCH 3036
4 XBRL LABEL FILE cocp-20250402_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cocp-20250402_pre.xml EX-101.PRE 24179
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3546
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 25822361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)